When to seek help
Review is commonly advised after a year of regular unprotected intercourse, or after six months when the woman is over 35. Earlier review may be sensible with irregular cycles, endometriosis, previous pelvic surgery, miscarriage, sexual difficulty or known male factors.
Age affects egg quantity and quality, so individual timing matters.
The basic work-up
A focused evaluation asks whether ovulation occurs, semen is adequate, tubes are open and the uterine cavity supports implantation. Tests may include cycle history, blood tests, ultrasound, semen analysis and tubal assessment.
Ovarian-reserve tests help planning but are not a yes/no fertility prediction. Sometimes standard tests are normal—called unexplained infertility.
Treatment pathways
Care can address timing, thyroid or prolactin problems, ovulation, endometriosis, fibroids, tubal disease and male factors.
Ovulation induction, IUI, surgery and IVF/ICSI have different indications, burdens, costs and risks. A staged plan should explain why and when to move on.
Why both partners are evaluated together
Infertility is not solely a women’s-health issue. Semen factors are common and can coexist with ovulation, tubal or uterine concerns. Beginning both sides of the evaluation together avoids months of sequential testing and reduces blame. A semen result may need confirmation because fever, illness, abstinence interval and laboratory variation can affect it.
For the woman, cycle history helps estimate whether ovulation occurs. Ultrasound examines the uterus and ovaries, while blood tests are selected rather than ordered as a universal panel. Tubal testing is important in many cases but its timing depends on infection history, previous surgery and the likely treatment path. No single “fertility test” predicts every couple’s chance.
Building a time-limited fertility plan
A good plan states the likely diagnosis, what remains uncertain, the chance of success, cost, burden and how many cycles will be tried before review. Timed intercourse or ovulation induction may be reasonable for one situation, while severe tubal or semen factors may lead to earlier IVF or ICSI discussion. Surgery helps selected structural problems, not every scan finding.
Emotional health and relationship strain are legitimate clinical concerns. Ask about counselling, medication safety and ways to reduce appointment burden. Supplements marketed for fertility vary in evidence and quality, and they should not delay effective evaluation. Treatment decisions should remain voluntary and should include alternatives, including pauses or choosing not to escalate.
What to bring to the first fertility visit
Bring dates of recent periods, pregnancy and miscarriage history, previous fertility treatment, operation notes and reports for both partners. Include medicines, supplements and relevant diabetes or thyroid records. The couple should be ready to discuss intercourse timing, sexual difficulty, infections and lifestyle without blame. Good fertility care protects privacy and explains why each test is ordered, how its result could change treatment and when the complete plan will be reviewed.
Questions patients commonly ask
When should a couple seek infertility advice?+
Common guidance is after 12 months of regular unprotected intercourse, or after six months when the woman is over 35. Irregular cycles or known risks justify earlier review.
Does a low AMH result mean pregnancy is impossible?+
No. AMH helps estimate ovarian response and egg quantity but does not by itself measure egg quality or prove whether natural conception can occur.
Is IVF always the first infertility treatment?+
No. Treatment follows the cause, age, duration and previous care. Some patients need timing advice, ovulation treatment, surgery or IUI; others benefit from earlier IVF.
Clinical references
This guide is informed by patient guidance from established public-health and professional medical bodies.